NCT02890173View on ClinicalTrials.gov

Study of CS-3150 in Patients With Essential Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

1,001

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

July 11, 2017

Study Completion Date

July 11, 2017

Conditions
Essential Hypertension
Interventions
DRUG

CS-3150

DRUG

Eplerenone

Trial Locations (1)

Unknown

Sapporo

Sponsors
All Listed Sponsors
lead

Daiichi Sankyo Co., Ltd.

INDUSTRY